CB Therapeutics

CB Therapeutics is headquartered in San Diego, CA.

Fermentation-derived natural products to solve health problems

Rare natural compounds (cannabinoids, alkaloids, tryptamines, etc.) are traditionally foraged or crop-extracted, subject to harvest seasonality and inconsistent supply.

Uses a precision fermentation platform to grow these compounds in yeast rather than sourcing them from plants, producing 100+ compounds across 8 compound classes.

AI-guided plan/build/test/iterate platform where lab data feeds back into design, 99.6% CBC purity benchmark, 8 US patents granted, a 16,000 sq ft Carlsbad, CA biomanufacturing facility, and 12 years of continuous operations.

Co-founded by Sher Butt and Jacob Vogan through Y Combinator (S18); the Carlsbad-based fermentation company closed an oversubscribed Series A led by re.Mind Capital in 2021.